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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S135speciﬁcally in the mesenchyme of developing limb buds as early as
embryonic day 9.5. These mice were then crossed to mice with condi-
tional (ﬂoxed) alleles of the Gsk3b gene, resulting in knockout (KO)
GSK-3b speciﬁcally in the limb buds. These KO mouse mutants were
then compared to their control littermates to examine any physical and
molecular differences through whole skeletal preparations, immuno-
histochemistry on tissue sections, and a variety of other techniques.
In addition to my in vivo studies, I will perform in vitro micromass
cultures utilizing both an adenoviral delivery of Cre recombinase
(with adenovirus-GFP as control) and pharmacological inhibitor to
inactivate GSK-3. The in vitro studies will allow for further investi-
gations into the molecular mechanisms associated with GSK-3 func-
tion in limb development, with a focus on the canonical Wnt/b-
catenin pathway.
C. Results: My preliminary analyses of the ﬁrst mutants I obtained
indeed suggest that their limbs are shorter, with a noted difference in
digit length. Tissue sections of different long bones show a slight
difference within the growth plate between the mutant mice and their
control littermates.
The in vitro micromasses cultures stained with alcian blue, which
represents glycosaminoglycans in cartilage, show an increase in alcian
blue stain with increasing concentration of the GSK-3 inhibitor SB86.
Real-time PCR data of day 3 micromasses treated with SB86 indicates
that there is a decrease in Aggrecan, Col2a1, and Sox9 markers, while
Col1a1 remains relatively stable. Preliminary western blots show an
increase in b-catenin accumulation within the micromasses treated
with increasing concentrations of SB86.
D. Conclusions: Together, these studies will provide insights into the
mechanisms controlling limb development. Previous studies indicate
that disruption of theWnt pathway, as we expect to occur in our model,
causes limb malformations including brachydactyly and syndactyly,
which are clinically important birth defects in humans. Our studies are
therefore highly relevant to these birth defects, as well as adult skeletal
diseases such as osteoarthritis that show a clear connection to skeletal
development.
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DIAGNOSTIC VALUE OF INTRA-ARTICULAR ANAESTHETIC HIP JOINT
INJECTION IN PATIENTS WITH ATYPICAL HIP PAIN: A SYSTEMATIC
REVIEW
D.M. Dorleijn, P.A. Luijsterburg, S.M. Bierma-Zeinstra, P.K. Bos. Erasmus
MC, Rotterdam, The Netherlands
Purpose: Pain in the hip region can arise from different sources. These
include intra-articular hip joint pathologies such as osteoarthritis,
acetabulofemoral impingement, labral pathology as well as extra-
articular causes such as greater trochanter pain syndrome, inguinal
hernia, and referred or radicular pain from the lumbosacral spine.
Although with careful history and examination hip osteoarthritis can
often be distinguished from other origins, sometimes symptoms are
atypical. In these cases, when total hip replacement surgery is being
considered, an intra-articular anaesthetic hip injection is frequently
used as a diagnostic tool for excluding or conﬁrming an intra-articular
source of hip pain.
To assess the diagnostic value of intra-articular anaesthetic hip injection
in patients with atypical hip pain.
Methods: Searched databases were PubMed, Embase, PEDro and the
Cochrane Library (until December 2011). Included were cohort studies,
randomized controlled trials and case series assessing the diagnostic
value of anaesthetic hip injections in differentiating between hip pain
caused by osteoarthritis or another source in patients with atypical hip
pain. Key terms used were: “osteoarthritis”, “hip”, “spine”, “diagnostic”
and “intra-articular”.
Two reviewers independently selected studies for inclusion, extracted
data and assessed methodological quality. Depending on homogeneity
of the studies, we calculated pooled estimates of sensitivity and spec-
iﬁcity with 95% conﬁdence intervals (CI).
Positive effect of total hip replacement surgery after a positive test and
positive effect of spinal treatment after a negative test were used as
reference test. Additional calculations were done for a total hip
replacement-only scenario.
Methodological quality of the studies was assessed with the Quadas2
tool.
Results: The search yielded 1387 eligible studies. Finally, 9 articles were
included representing 556 patients with hip pain; seven studies were
included in the meta-analysis.The studies were heterogeneous as to patient characteristics and
outcome measurements.
The pooled estimates of sensitivity and speciﬁcity were .97 (95% CI .87,
.99) and .91 (95% CI .83, .95). This corresponds with a positive likelihood
ratio of 10.6 (95% CI 5.6, 20.1) and a negative likelihood ratio of 0.04
(95% CI 0.01, 0.15).
The total hip replacement-only scenario contained patients who had
received a total hip replacement and their pain outcome was scored
afterwards. The pooled estimates of sensitivity and speciﬁcity were .96
(95% CI .87, .99) and .42 (95% CI .09, .84).
Conclusions: These results show that complete or partial hip pain relief
after intra-articular anaesthetic hip injection is reasonably predictive of
pain relief after total hip replacement surgery. However, the value of
a negative test (no pain relief after hip injection) is unclear. As our
results may have been inﬂuenced by heterogeneity and missing data,
the evidence for the diagnostic value of an intra-articular anaesthetic
hip injection is not conclusive.
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ASSESSING HAND OSTEOARTHRITIS USING DIGITAL PHOTOGRAPHS
IN A COMMUNITY-DWELLING POPULATION: RELIABILITY AND
ASSOCIATIONS WITH RADIOGRAPHIC AND CLINICAL FEATURES
M. Marshall y, H. Jonsson z, G.P. Helgadottir x, E. Nicholls y, D. van der
Windt y, H. Myers y, K. Dziedzic y. yKeele Univ., Staffordshire, United
Kingdom; z Landspitalinn Univ. Hosp., Univ. of Iceland, Reykjavik,
Iceland; xUniv. of Iceland, Reykjavik, Iceland
Purpose: An atlas for grading hand osteoarthritis (OA) on photographs
has been shown to be reliable and associated with clinical examination
and radiographic features in a population of older adults (aged 69
years) from the AGES-Reykjavik study. The objective of this research
was to determine if this atlas was reliable and to assess its association
with radiographic and clinical features in a different younger commu-
nity-dwelling population.
Methods: Participants were community-dwelling older adults (50
years) in North Staffordshire, UK with self-reported hand pain or hand
problems in the last year who attended a research clinic. High quality
photographs taken at a set distance in a standardised position were
graded for the presence of hand OA using an established atlas. Hand
radiographs were graded for OA using the Kellgren Lawrence grading
system and the presence of clinical features (nodes, bony enlargement,
deformity)wasdeterminedonphysical examinationby trainedassessors.
Results: Following exclusions 558 participants (mean age 64 years, 62%
female) were included in the analyses. Overall reliability for scoring
each joint and joint group was good (mean intra-rater ICC ¼0.79, mean
inter-rater ICC¼0.71). For each joint and joint group photographic hand
OA was positively associated with grade of radiographic OA (rho 0.19-
0.57, p<0.001) and the number of clinical features present on an
examination (rho 0.36-0.59, p<0.001). At the person level, individuals
with higher global photographic hand OA scores had higher summed
K&L scores and had higher percentages meeting the ACR clinical hand
OA criteria.
Conclusions: This photographic scoring system for hand OA has been
shown to be reliable and associated with both radiographic and clinical
features in a different and younger community-dwelling population to
that in which it was developed. This method of data collection offers
researchers an feasible alternative to the physical examination and
maybe of particular use to large studies and those spread over a wide
geographic areas.
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LOW SURGEON VOLUME IS ASSOCIATED WITH INCREASED
COMPLICATIONS FOLLOWING TOTAL HIP ARTHROPLASTY, AFTER
ACCOUNTING FOR EXPERIENCE
B. Ravi y, R. Croxford z, G.A. Hawker y. yUniv. of Toronto, Toronto, ON,
Canada; z Inst. of Clinical Evaluative Sci. (ICES), Toronto, ON, Canada
Purpose: Provider volume-outcome relationships for total hip arthro-
plasty (THA) have been demonstrated in the US, but, to date, not in
Canada. Potential explanations for differences include a relatively low
proportion of surgeons in Canada with low arthroplasty volumes. A
previous study which examined this relationship in Canada pooled the
surgeon's total volume over the entire time period, to avoid penalizing
surgeons with less experience. We sought to re-examine this issue by
determining the surgeon's procedure volume in the year prior to the
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analysis excluding these surgeons.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA between 2002-2009 utilizing health administra-
tive databases from Ontario, Canada. We excluded those who had
received a primary or revision arthroplasty of the hip or knee prior to
April 1, 2002, and those whose ﬁrst procedure was non-elective (e.g. for
cancer, fracture, or external cause of injury), or if the patient had
a diagnosis of an inﬂammatory arthritis. Surgeon volume was deter-
mined by pooling the number of primary and revision THAs performed
by the primary surgeon in the 365d prior to the surgery and catego-
rizing by quartiles (lowest: 30; 2nd: 31-50; 3rd: 51-75; 4th: >75 cases).
Generalized estimating equations were used to determine the rela-
tionship between volume quartile and the occurrence of speciﬁc
complications (within 90d: DVT/PE, AMI; within 2y: dislocation,
infection and revision) after controlling for potential confounders
(income quintile, rurality, prior intra-articular injection, and hospital
volume), and accounting for clustering by surgeons. We repeated our
analysis after excluding patients of surgeons who had graduated from
medical school less than years before performing the THA. A propensity
score for treatment by the lowest quartile, versus any of the other
quartiles, was developed and used as a balancing score. The number
needed to harm (NNH) for each complication was then determined.
Results: Between April 1, 2002 and March 31, 2009, there were 37,881
THA recipients (lowest volume quartile: 7,267 patients; 2nd: 9,307
patients; 3rd: 9,566 patients; highest volume quartile: 11,741 patients).
Relative to the highest surgeon volume quartile of hip replacements,
THA recipients in the lowest quartile were more likely to be female
(lowest: 57.1%, highest: 53.2%, p<0.001), older (lowest: mean age 68.1y,
highest: 63.6y, p<0.001), and reside in a rural area (p<0.001).
Controlling for these differences, and for clustering among surgeons,
THA recipients treated by surgeons in the lowest volume quartile were
at increased risk of dislocation (adjusted OR 1.60, 95%CI 1.26, 2.05,
p<0.0001) and revision within 2y of THA (adjusted OR 1.59, 95%CI 1.25,
2.02, p¼0.0002) relative to all other THA recipients. This increased risk
persisted after excluding surgeons with less experience (dislocation:
adjusted OR 1.63, 95%CI 1.24, 2.14, p¼0.0004; revision: adjusted OR
1.49, 95%CI 1.11, 1.98, p¼0.0071). Propensity score matching matched
6,827 patients who received their THA from a surgeon in the lowest
volume quartile (94% of potential cases) with 15,840 patients who
received their THA from a surgeon in any of the other volume quartile
(52% of potential controls). The number needed to harm for THA
recipients who received their THA from a surgeon in the lowest volume
quartile was 149 patients for dislocation, and 167 patients for revision
within 2years.
Conclusions: Patients who receive their THA by surgeons in the lowest
volume quartile (deﬁned here as 30 or fewer cases annually) had
increased risk for early revision and dislocation. This increased risk
persists after accounting for lack of surgeon experience. To our
knowledge, this is the ﬁrst study to demonstrate this relationship in
Canada, and to quantify the added risk.248
THREE TRAJECTORIES OF ACTIVITY LIMITATIONS IN EARLY
SYMPTOMATIC KNEE OSTEOARTHRITIS: A 5-YEAR FOLLOW-UP
STUDY
J. Holla y, M. van der Leeden y, M. Heymans z, L. Roorda y, S. Bierma-
Zeinstra x, M. Boers z, W. Lems z, M. Steultjens k, J. Dekker z. yReade,
Rheumatology and Rehabilitation, Amsterdam, The Netherlands; zVU
Univ. Med. Ctr., Amsterdam, The Netherlands; x Erasmus Univ. Med. Ctr.,
Rotterdam, The Netherlands; kGlasgow Caledonian Univ., Glasgow,
United Kingdom
Purpose: Osteoarthritis (OA) is a leading cause of activity limitations
among older adults. The knee OA population is heterogeneous and is
likely to consist of subgroups with distinct trajectories of activity limi-
tations. The aim of the present study was to identify homogeneous
subgroups with distinct trajectories of activity limitations in patients
with early symptomatic knee OA, and to describe characteristics of
these subgroups.
Methods: Follow-up data over a period of ﬁve years of 697 participants
with early symptomatic knee OA from the Cohort Hip and Cohort Knee
(CHECK) were used. Activity limitations were measured yearly (six
measurements over time) with the Western Ontario and McMasterUniversities Osteoarthritis Index. Latent class growth analyses identi-
ﬁed homogeneous subgroups with distinct trajectories of activity
limitations. Multivariable regression analyses examined differences in
characteristics between the subgroups.
Results: Three subgroups were identiﬁed. Participants in Subgroup 1
(‘good outcome’; n¼330) developed or displayed slight activity limita-
tions over time. Participants in Subgroup2 (‘moderate outcome’; n¼257)
developed or displayed moderate activity limitations over time. Partic-
ipants in subgroup 3 (‘poor outcome’; n¼110) developed or displayed
severe activity limitations over time. Compared to the ‘good outcome’
subgroup, the ‘moderate outcome’ and ‘poor outcome’ subgroups were
characterized by: younger age, higher body-mass index, greater pain,
bony tenderness, reduced knee ﬂexion, hip pain, osteophytosis, 3
comorbidities, lower vitality, or avoidance of activities.
Conclusions: Based on the 5-year course of activity limitations exam-
ined in our study, we identiﬁed homogeneous subgroups of knee OA
patients with good, moderate or poor outcome. Characteristics of these
subgroups were consistent with existing knowledge on prognostic
factors regarding activity limitations, which supports the validity of this
classiﬁcation. Identiﬁcation of homogeneous subgroups may contribute
to the development of tailored preventive interventions in knee OA
patients.249
DO HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS ASSOCIATE
WITH RADIOGRAPHIC PROGRESSION IN EARLY RHEUMATIOD
ARTHRITIS AND HAND OSTEOARTHRITIS?
I.R. Klein-Wieringa, S.N. Andersen, J.C. Kwekkeboom, L. Herb-van
Toorn, A. van der Helm-van Mil, I. Meulenbelt, T.J. Huizinga, M.
Kloppenburg, R.E. Toes, A. Ioan-Facsinay. Leiden Univ. Med. Ctr., Leiden,
The Netherlands
Purpose: Adipose tissue can secrete many different soluble factors
(adipokines) inﬂuencing whole body metabolism. Some of these adi-
pokines, such as adiponectin, have been shown to inﬂuence radio-
graphic progression in osteoarthritis (OA) and rheumatoid arthritis
(RA). In RA patients, total adiponectin (totAPN) levels in serum associate
positively with radiographic progression, which suggestes an adverse
effect on disease. Intruiguingly, in patients with hand OA, high totAPN
levels in serum associated with a decreased relative risk for radio-
graphic progression, suggesting a beniﬁcial effect on disease.
Adiponectin is a pleiotropic adipokine, which consists of several iso-
forms. Of these isoforms, high molecular weight adiponectin
(hmwAPN) has been described as one of the most biologically active
and its effect on radiographic progression in RA and hand OA is
unknown. Therefore, we explored the possibility that the association
between totAPN and disease progression is primarily mediated by the
hmwAPN isoform.
Methods: Concentrations of hmwAPN and totAPN were determined in
baseline plasma of 324 RA patients from the Early Arthritis Cohort
(EAC) and in baseline sera of 164 hand OA patients from the Genetics
Arthrosis and Progression (GARP) study. The association between
levels of hmwAPN and totAPN with radiographic progression were
determined using a multivariate normal regression model (EAC cohort)
or by generalized estimated equations (GARP cohort). Adjustments
were made for age, gender, treatment strategy and Body Mass Index
(BMI).
Results: In RA patients totAPN associated positively with radiographic
progression (Sharp van der Heijde scores) (association estimate 3.65,
p ¼ 0.002), whereas in patients with hand OA, totAPN associated
negatively with radiographic progression (joint space narrowing
(JSN)) (Odds 0.24/ Odds 0.21, p ¼ 0.002/ p ¼ 0.002 two highest tertiles
compared to the lowest tertile). HmwAPN on the other hand, did not
associate signiﬁcantly with radiographic progression in patients with
hand OA or RA, although in patients with RA we did observe a trend
towards a positive association (association estimate 1.53 p ¼ 0.07)
upon correcting for age, gender and treatment strategy. This trend
was lost after further adjustment for BMI. Similar results were ob-
tained when joint space narrowing (JSN) was used as outcome
measurement.
Conclusions: Our data further substantiate the connection between
APN-levels and radiographic progression in rheumatic disease and
indicate that the differential effects associated between totAPN and
radiographic progression in either in RA and hand OA is not mediated
by (a selective effect of) hmwAPN.
